NCT05780333

Brief Summary

The goal of this clinical trial is to evaluate in effect of tap block and esp block on quality of recovery and postoperative pain after laparoscopic hysterectomy. The main question it aims to answer are: Are these two plane blocks used superior to each other? Participants;

  • will fill out the preoperative questionnaire
  • will fill out the postoperative questionnaire
  • will report their pain status according to the NRS score

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 27, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 4, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 22, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

March 27, 2023

Status Verified

March 1, 2023

Enrollment Period

5 months

First QC Date

March 4, 2023

Last Update Submit

March 23, 2023

Conditions

Keywords

tap blockesp blockpostoperative painrecovery

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery 40 Questionnaire

    The global Quality of Recovery-40 aggregate score is a scale from (1 to 5, where: 1 = very poor and 5 = excellent)

    24 hours after surgery.

Secondary Outcomes (1)

  • Postoperative pain

    24 hours after surgery.

Other Outcomes (1)

  • using salvage opiod

    24 hours after surgery.

Study Arms (2)

tap block

OTHER

Tap block is one of the frequently used field blocks for analgesia management of abdominal surgery. At the end of surgery and general anesthesia, transversus abdominis fascial plane will be detected with using lineer usg probe. With in-plane tecnique after placement of the needle in the transversus abdominis fascial plane, and careful aspiration to exclude vascular puncture, a test dose of 1 mL will be injected to determine resistance to flow, and confirm needle tip placement within the fascial plane. After this, 20 ml local anaestetic mixture will be injected through the needle. The TAP block will be then performed on the opposite side using an identical technique.

Procedure: TAP block

esp block

ACTIVE COMPARATOR

The effectiveness of esp block is also evaluated in abdominal surgery after spinal surgery, thoracic and cardiovascular surgery. At the end of surgery and general anesthesia, in the lateral decubitus position, the linear probe will be placed approximately 3 cm lateral to the T10 spinous process, in the parasagittal plane. With the in-plane technique, when the block needle rests on the transverse process (approximately 3cm in depth), the erector spina plan will be confirmed with a 0.5-1 mL 0.9% NaCl test dose. 20 ml of local anesthetic mixture will be applied to the confirmed area. The procedure will be applied bilaterally.

Procedure: ESP block

Interventions

TAP blockPROCEDURE

Bilateral tap block with 20 ml of mixture 2:1:1 (0.5% bupivacaine: 0.9%NaCl: 2% lidocain) for each

tap block
ESP blockPROCEDURE

Bilateral esp block with 20 ml of mixture 2:1:1 (0.5% bupivacaine: 0.9%NaCl: 2% lidocain) for each

esp block

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIt will be planned for female gender as patients who have undergone hysterectomy will be selected.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients who will undergo hysterectomy under elective conditions
  • years
  • ASA I-II patients

You may not qualify if:

  • Refusal during registration, request to be excluded from the study, failure to give informed consent
  • Under 18 years old and upper 65 years old
  • ASA III-IV patients
  • Chronic opioid use
  • Presence of infection at the injection site
  • Renal failure / Liver failure
  • Bupivacaine sensitivity
  • Use of anticoagulants
  • BMI \< 18,5 , BMI \>35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pelin Dilsiz Eker

Muğla, Menteşe, 48050, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Yap JY, Bhat M, McMullen W, Ragupathy K. Novel use of laparoscopic-guided TAP block in total laparoscopic hysterectomy. J Obstet Gynaecol. 2018 Jul;38(5):736. doi: 10.1080/01443615.2018.1444402.

  • Rosato C, Santonastaso DP, de Chiara A, Viola L, Russo E, Piccioni FG, Agnoletti V. Erector spinae plane block for pain management in laparoscopic hysterectomy and bilateral oophorectomy. J Clin Anesth. 2021 Jun;70:110184. doi: 10.1016/j.jclinane.2021.110184. Epub 2021 Feb 6. No abstract available.

  • Yagi K, Adachi K, Tanaka E, Toda A, Miyoshi Y, Funada R, Yamamoto Y. The Role of Preoperative and Postoperative Transversus Abdominis Plane and Rectus Sheath Block in Patients Undergoing Total Laparoscopic Hysterectomy. J Perianesth Nurs. 2020 Oct;35(5):491-495. doi: 10.1016/j.jopan.2020.02.014. Epub 2020 Jun 18.

Related Links

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • pelin dilsiz eker, MD

    Mentese State Hospital

    PRINCIPAL INVESTIGATOR
  • Ismail Gökbel, MD

    Mentese State Hospital

    STUDY CHAIR
  • Sinem Sari Ozturk, MD

    Aydin Adnan Menderes University, Department of anesthesiology and reanimation

    STUDY DIRECTOR

Central Study Contacts

Pelin dilsiz eker, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Triple (Participant, Care Provider, Investigator)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a double blind, randomized control clinical trial.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD., specialist

Study Record Dates

First Submitted

March 4, 2023

First Posted

March 22, 2023

Study Start

January 27, 2023

Primary Completion

June 30, 2023

Study Completion

July 1, 2023

Last Updated

March 27, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations